2/12
02:37 pm
arct
Arcturus Therapeutics: Two Catalysts, One Runway, And A Stock Priced For Failure [Seeking Alpha]
Neutral
Report
Arcturus Therapeutics: Two Catalysts, One Runway, And A Stock Priced For Failure [Seeking Alpha]
2/9
02:21 pm
arct
Citi Lowers Price Target on Arcturus Therapeutics Holdings Inc. (ARCT) to $7, Maintains Neutral Rating [Yahoo! Finance]
Low
Report
Citi Lowers Price Target on Arcturus Therapeutics Holdings Inc. (ARCT) to $7, Maintains Neutral Rating [Yahoo! Finance]
2/2
10:00 am
arct
Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARCT) Pipeline Assets [Yahoo! Finance]
Low
Report
Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARCT) Pipeline Assets [Yahoo! Finance]
1/24
06:28 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) was upgraded by analysts at Roth Mkm to a "strong-buy" rating.
Low
Report
Arcturus Therapeutics (NASDAQ:ARCT) was upgraded by analysts at Roth Mkm to a "strong-buy" rating.
1/23
05:06 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/22
05:08 pm
arct
Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at Roth Mkm. They set a "buy" rating on the stock.
Medium
Report
Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at Roth Mkm. They set a "buy" rating on the stock.
1/10
03:09 pm
arct
1 Under-$10 Stock Set to Surge as Much as 963% in 2026 [Yahoo! Finance]
High
Report
1 Under-$10 Stock Set to Surge as Much as 963% in 2026 [Yahoo! Finance]
1/8
05:47 pm
arct
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/8
05:30 pm
arct
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/6
01:58 pm
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Citigroup Inc. from $9.00 to $7.00. They now have a "neutral" rating on the stock.
Low
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its price target lowered by analysts at Citigroup Inc. from $9.00 to $7.00. They now have a "neutral" rating on the stock.
1/6
06:21 am
arct
Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines [Yahoo! Finance]
Low
Report
Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines [Yahoo! Finance]
11/24
04:01 pm
arct
Arcturus Therapeutics to Attend Upcoming Investor Conference
Medium
Report
Arcturus Therapeutics to Attend Upcoming Investor Conference